Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer
isPeerReviewed
numberOfPages
abstract
<p>Mutational processes underl ...... germline NTHL1 mutations.</p>
@en
authorList
type
label
Use of CRISPR-modified human s ...... utational signatures in cancer
category
electronicVersions
externalOrganisations
journalAssociation
journalNumber
keywordGroups
language
managingOrganisationalUnit
openAccessPermission
organisationalUnits
publicationStatuses
relatedPressMedia
totalScopusCitations
visibility
Publiek - Geen beperking
@nl
workflow
Validated
@en
author
datePublished
2017-10-13